SeaStar Medical is trading at $2.35, down 5.24%, as no clear catalyst for the October 29 decline surfaced in the sources reviewed.
- The latest identified company news was an October 22 clinical-data release.
- The broader market was weaker, particularly the Nasdaq, while healthcare was reported higher; available evidence does not establish a market or sector cause.
- No volume or other trading-activity figures were available in the provided price context.